TELA Bio (TELA) Enterprise Value (2018 - 2026)

TELA Bio's Enterprise Value history runs 9 years deep, the most recent figure standing at -$39.5 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 7.69% year-over-year to -$39.5 million in Q1 2026; TTM through Mar 2026 was -$39.5 million, a 7.69% increase from a year earlier, with the FY2025 full-year figure at -$50.8 million, up 3.46% from the prior year.
• Enterprise Value climbed to -$39.5 million in Q1 2026 per TELA's latest filing, from -$50.8 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$17.3 million in Q3 2024 and bottomed at -$65.3 million in Q2 2023.
• The 5-year median for Enterprise Value is -$39.5 million (2026), against an average of -$40.5 million.
• Across the five-year window, Enterprise Value sank 135.4% in 2023 and soared 70.27% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$42.0 million in 2022, then dropped by 11.21% to -$46.7 million in 2023, then dropped by 12.71% to -$52.7 million in 2024, then rose by 3.46% to -$50.8 million in 2025, then climbed by 22.23% to -$39.5 million in 2026.
• Per Business Quant, the three latest TELA Enterprise Value figures stand at -$39.5 million (Q1 2026), -$50.8 million (Q4 2025), and -$29.7 million (Q3 2025).